SGP · SpyGlass Pharma, Inc.
$26.51
+0.28 (+1.07%)
At close · Aug 21
Market Cap
$886.71M
Shares
33.45M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $0 | 10-Q, filed 2026-08-06 |
| 2025-12-31 | $1,450,000 | 10-K, filed 2026-03-26 |
| 2024-12-31 | $0 | 10-K, filed 2026-03-26 |
Key facts
CIK
1778922
CUSIP
85220G109
13F (30d)
51 filings
51 filers
Visit website
Investor relations